‹‹ Zurück zur Startseite


1. Kotter I, Vonthein R, Gunaydin I, et al. Behcet's disease in patients of German and Turkish origin--a comparative study. Adv Exp Med Biol 2003; 528:53-8.
2. Kotter I, Gunaydin I, Stubiger N, et al. Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin. Tissue Antigens 2001; 58:166-70.
3. Behcet H. Über rezidivierende, aphthöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien. Dermatol. Wschr. 1937; 105:1152-1157.
4. Adamantiades B. A case of relapsing iritis with hypopion (in Greek). Archia Iatrikis Etairas (Proceedings of hte Medical Society of Athens) 1930:586-539.
5. Dilsen N. History and development of Behcet's disease. Rev Rhum Engl Ed 1996; 63:512-9.
6. Zouboulis CC, Keitel W. A historical review of early descriptions of Adamantiades-Behet`s disease. J Invest Dermatol 2002; 1:201-205.
7. Kotter I, Zierhut M, Eckstein A, et al. Human recombinant interferon-lpha2a for the treatment of Behcet`s disease with sight threatening posterior or panuveitis. Br J Ophthalmol 2003; 87:423-431.
8. Kotter I, Vonthein R, Zierhut M, et al. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behcet disease: results of an open 4-center trial. Semin Arthritis Rheum 2004; 33:311-9.
9. Kotter I, Gunaydin I, Zierhut M, Stubiger N. The use of interferon alpha in Behcet disease: review of the literature. Semin Arthritis Rheum 2004; 33:320-35.
10. Deuter CM, Kotter I, Gunaydin I, Zierhut M, Stubiger N. [Ocular involvement in Behcet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]. Ophthalmologe 2004; 101:129-34.
11. Deuter CM, Zierhut M, Möhle A, Vonthein R, Stübiger N, Kötter I. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum. 2010 Sep;62(9):2796-805.
12. Dilsen N, Konice M, Aral O. Our diagnostic criteria of Behcet`s Disease - an overview, Recent advances in Behcet`s Disease, London, 1985. Royal Society of Medicine Services.
13. Mason RM, Barnes CG. Behcet's syndrome with arthritis. Ann Rheum Dis 1969; 28:95-103.
14. O`Duffy JD. Critères proposés pour le diagnostic de la maladie de Behcet. Rev Med 1974; 36:2371-2379.
15. Mizushima Y. [Revised diagnostic criteria for Behcet's disease in 1987]. Ryumachi 1988; 28:66-70.
16. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990; 335:1078-80.
17. Kotter I, Durk H, Saal J, Fierlbeck G, Pleyer U, Ziehut M. Therapy of Behcet's disease. Ger J Ophthalmol 1996; 5:92-7.
18. Kotter I, Eckstein AK, Stubiger N, Zierhut M. Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol 1998; 82:488-94.
19. Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N. Behcet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 2004; 31:133-9.
20. Treusch M, Stubiger N, Vonthein R, et al. Influence of interferon-alpha on lymphocyte subpopulations in Behcet's disease. Adv Exp Med Biol 2003; 528:533-5.
21. Zierhut M, Saal J, Pleyer U, Kotter I, Durk H, Fierlbeck G. Behcet's disease: epidemiology and eye manifestations in German and Mediterranian patients. Ger J Ophthalmol 1995; 4:246-51.
22. Zouboulis CC, Kotter I, Djawari D, et al. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J 1997; 38:411-22.
23. Zouboulis Ch C, Kotter I, Djawari D, et al. Current epidemiological data from the German Registry of Adamantiades-Behcet's disease. Adv Exp Med Biol 2003; 528:43-8.